Epclusa▼ 200 mg/50 mg film-coated tablets (sofosbuvir/velpatasvir): supply of Irish product

Due to supply disruption, Gilead has obtained approval from MHRA to supply Irish product, which is expected to be on UK market until 30th June 2021. It has same formulation as UK product but there are minor differences between the Irish and UK product information.

Gilead Sciences Ltd